EP3458054
USE OF GLUTAMATE MODULATING AGENTS WITH IMMUNOTHERAPIES TO TREAT CANCER
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
19.5.2017EP published:
23.2.2022EP application number:
17800311.7
EPO information:
European Patent Register
Max expiry date:
18.5.2037
Title in English:
USE OF GLUTAMATE MODULATING AGENTS WITH IMMUNOTHERAPIES TO TREAT CANCERLanguage of the patent:
English
Timeline
Today
19.5.2017EP application
23.2.2022EP Publication
Owner
Name:
Biohaven Pharmaceutical Holding Company Ltd.Address:
234 Church Street Suite 301, New Haven, CT 06520, US
Inventor
Name:
CORIC, VladimirAddress:
New Haven Connecticut 06520, US
Priority
Number:
201662339433 PDate:
20.5.2016Country:
US
Classification
Categories:
A61K 31/428, C07D 277/82